Supply Chain

The FDA on Monday granted approval to CutisPharma's drug Firvanq to treat Clostridium difficile-associated diarrhea and Staphylococcus aureus-associated intestinal inflammation (enterocolitis).

The FDA on Tuesday placed a clinical hold on Bellicum Pharmaceuticals' T-cell therapy trial after three patients developed encephalopathy, reports Genetic Engineering and Biotechnology News.

President Donald Trump identified lowering drug prices and expanding patient access to experimental medications as top priorities for his administration during his State of the Union address Tuesday night, reports CNN.

Although drug advertisements are prominently showcased throughout regular TV programming, they will take a back seat during this year's Super Bowl, according to MM&M.

President Donald Trump swore in Alex Azar as HHS secretary Monday. During the ceremony, the president renewed his pledge to lower drug prices and said the initiative would be one of Mr. Azar's biggest priorities in his new role, reports…

Health systems will see a 7.35 percent price increase for drug purchases through mid- 2019, according to estimates from Vizient's January 2018 Drug Price Forecast.

Effective Feb. 5, Bob Hugin, executive chairman of pharmaceutical giant Celgene, will step down, according to Street Insider.

As the nation grapples with a widespread flu outbreak and states continue to see spikes in flu activity, some pharmacies throughout Florida are struggling to keep up with the demand of the antiviral drug Tamiflu, reports the Orlando Sentinel.

The FDA granted approval Friday to Advanced Accelerator Applications for its drug Lutathera, which treats cancer that affects the pancreas or gastrointestinal tract.

U.S. physicians indicate an almost 50-50 split when asked whether trackable pills will improve patient outcomes, according to a recent survey by SERMO, a global social network for physicians.